Skip to content

Women and Risk of Type 2 Diabetes

Women and Risk of Type 2 Diabetes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03870724
Enrollment
383
Registered
2019-03-12
Start date
2019-08-27
Completion date
2022-03-30
Last updated
2022-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus

Keywords

Prevention, Cardiovascular diseases, Physical activity, Ethnic differences in health, Risk factors

Brief summary

This is a follow-up survey of women, 10-12 years after they were included in the population-based Stork Groruddalen study of pregnant women, primarily set up to study gestational diabetes and related health issues in pregnancy in a multiethnic population. The investigators will now update the information about the health status of these women to study the development of risk factors for type 2 diabetes and cardiovascular diseases.

Detailed description

The STORK-Groruddalen is a cohort study of 823 pregnant women. Participation rate was high due to facilitation for ethnic minorities and data collection at the local Health Centres, set up to study ethnic differences in health to inform prevention strategies to reduce these differences. The investigators have published many papers from this well charatertized cohort, about gestational diabetes and related health issues in pregnancy. Participants have agreed to be contacted for subsequent follow-up surveys. The inivestigators are now planning a follow-up study of these woman during 2019-2022, to study trajectories for risk factors for type 2 diabetes and cardiovascular diseases such as BMI, blood pressure, lipids, behavioural factors, physical activity and mental health and other health issues. The investigators will collect selfreported information through questionnaires, perform clinical measurements and take blood samples and buccal swabs. Collecting updated information about a range of health outcomes for women in this cohort will, together with already collected data, enable us to study the development of risk factors for type 2 diabetes and cardiovascular diseases in a life course perspective.

Interventions

None listed

Sponsors

Norwegian Diabetes Association
CollaboratorOTHER
University of Oslo
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
27 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Previous participants in the STORK G study still living in Norway

Exclusion criteria

* Moved out of Norway

Design outcomes

Primary

MeasureTime frameDescription
Type 2 diabetes2 yearsPrevalence

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026